FSP1 expression is markedly upregulated in CRC tissues compared to that in adjacent normal tissues, and this increase is strongly associated with advanced tumor–node–metastasis (TNM) stages, lymph node involvement, distant metastasis, and unfavorable patient outcomes [50]. The gene discussed is AIFM2; the disease is neoplasm.